Simplex Trading’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-61,800
Closed -$1.32M 10120
2024
Q1
$1.32M Buy
61,800
+54,000
+692% +$646K ﹤0.01% 2831
2023
Q4
$74K Buy
+7,800
New +$37.9K ﹤0.01% 5693

Simplex Trading's FUSN Position: Q1 2024 in Review

Simplex Trading sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q1 2024, closing a stake of 12,501 shares — an estimated $150K sold.

Simplex Trading first reported a position in FUSN in Q2 2021 and held it in 7 quarters. The position peaked at $120K in Q4 2023. 114 funds tracked by Wall St. Rank hold FUSN as of Q1 2024.

  • Simplex Trading reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 12,501 Fusion Pharmaceuticals Inc. Common Shares shares in Q1 2024, an estimated $150K.
  • Simplex Trading first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2021 and held it in 7 quarters.
  • Simplex Trading's Fusion Pharmaceuticals Inc. Common Shares position peaked at $120K in Q4 2023.
  • 114 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.